Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EPH Receptor B2 (EPHB2) (C-Term) Peptide

EPHB2 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5513369
  • Target See all EPH Receptor B2 (EPHB2) products
    EPH Receptor B2 (EPHB2)
    Protein Region
    C-Term
    Origin
    Human
    Source
    • 5
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    PRATGRTKRC QPRDVTKKTC NSNDGKKKGM GKKKTDPGRG REIQGIFFKE
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-EPHB2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    EPH Receptor B2 (EPHB2)
    Background
    This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants.

    Alias Symbols: DRT, EK5, ERK, CAPB, Hek5, PCBC, EPHT3, Tyro5

    Protein Size: 1055
    Gene ID
    2048
    NCBI Accession
    NM_001309193, NP_004433
    UniProt
    P29323
You are here:
Support